Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Alpha Cognition and China Medical System sign a $44M licensing deal for Zunveyl. ALPHA-1062 preclinical data shows benefits ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental When it comes to what they pay for their ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Scientists are looking at how DNA differences could protect people from dementia – and how this can help others ...